|Articles|November 15, 2019
The Ins and Outs of Incorporating Patient Centricity in Drug Development
Author(s)Parexel
Trending on PharmExec
1
FDA Approves Lipfendra to reduce LDL-C in Adults with Hypercholesterolemia
2
Eli Lilly to Acquire AtaiBeckley for $2.8 Billion
3
Pharmaceutical Executive Daily: FDA Approves Lipfendra
4
The Power of Better Questions: How Great Leaders Balance Risk, Growth and Curiosity
5